Literature DB >> 3123980

Tolerance to opioids in single locus coeruleus neurons of the rat.

M J Christie1, J T Williams, R A North.   

Abstract

Chronic treatment of rats with morphine caused tolerance to the membrane hyperpolarizing action of morphine in single locus coeruleus neurons in vitro. Tolerance was less pronounced for Try-D-Ala-Gly-MePhe-Gly-ol (DAGO) than for normorphine. No changes were found in affinity of naloxone for mu-receptors on these neurons, nor in the properties of the potassium conductance increase caused by mu-receptor activation. These results suggest that the mechanisms underlying tolerance involve either a reduction of the number of mu-receptors on each cell, or a reduced coupling of mu-receptors to potassium channels.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3123980

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN: 1046-9516


  4 in total

1.  Morphine-induced trafficking of a mu-opioid receptor interacting protein in rat locus coeruleus neurons.

Authors:  Kellie M Jaremko; Nicholas L Thompson; Beverly A S Reyes; Jay Jin; Brittany Ebersole; Christopher B Jenney; Patricia S Grigson; Robert Levenson; Wade H Berrettini; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-12-12       Impact factor: 5.067

2.  Chronic intrathecal morphine treatment does not cause down-regulation of spinal adenosine A1 receptors in rats.

Authors:  P L Tao; C S Wong; M C Lin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

3.  Pre- and postsynaptic regulation of locus coeruleus neurons after chronic morphine treatment: a study of GIRK-knockout mice.

Authors:  Maria Torrecilla; Nidia Quillinan; John T Williams; Kevin Wickman
Journal:  Eur J Neurosci       Date:  2008-08       Impact factor: 3.386

4.  Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitization.

Authors:  Michael S Virk; John T Williams
Journal:  Mol Pharmacol       Date:  2008-01-15       Impact factor: 4.436

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.